These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15875225)

  • 21. [Level of evidence for therapeutic drug monitoring of voriconazole].
    Hulin A; Dailly E; Le Guellec C;
    Therapie; 2011; 66(2):109-14. PubMed ID: 21635857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of voriconazole in critically ill patients with invasive mycoses].
    Alvarez Lerma F
    Rev Iberoam Micol; 2007 Sep; 24(3):209-12. PubMed ID: 17874857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Switching from intravenous to oral tacrolimus and voriconazole leads to a more pronounced drug-drug interaction.
    Spriet I; Grootaert V; Meyfroidt G; Debaveye Y; Willems L
    Eur J Clin Pharmacol; 2013 Mar; 69(3):737-8. PubMed ID: 22878691
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacokinetic interaction between voriconazole and ciclosporin A following allogeneic bone marrow transplantation.
    Groll AH; Kolve H; Ehlert K; Paulussen M; Vormoor J
    J Antimicrob Chemother; 2004 Jan; 53(1):113-4. PubMed ID: 14657088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Voriconazole pharmacokinetics and pharmacodynamics in children.
    Neely M; Rushing T; Kovacs A; Jelliffe R; Hoffman J
    Clin Infect Dis; 2010 Jan; 50(1):27-36. PubMed ID: 19951112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horses.
    Clode AB; Davis JL; Salmon J; Michau TM; Gilger BC
    Am J Vet Res; 2006 Feb; 67(2):296-301. PubMed ID: 16454636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between trough plasma and epithelial lining fluid concentrations of voriconazole in lung transplant recipients.
    Heng SC; Snell GI; Levvey B; Keating D; Westall GP; Williams TJ; Whitford H; Nation RL; Slavin MA; Morrissey O; Kong DC
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4581-3. PubMed ID: 23817382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disposition of voriconazole during continuous veno-venous haemodiafiltration (CVVHDF) in a single patient.
    Robatel C; Rusca M; Padoin C; Marchetti O; Liaudet L; Buclin T
    J Antimicrob Chemother; 2004 Jul; 54(1):269-70. PubMed ID: 15175271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Voriconazole. UK 109496.
    Drugs R D; 1999 Feb; 1(2):187-8. PubMed ID: 10566023
    [No Abstract]   [Full Text] [Related]  

  • 30. Voriconazole plasma levels in children are highly variable.
    Spriet I; Cosaert K; Renard M; Uyttebroeck A; Meyts I; Proesmans M; Meyfroidt G; de Hoon J; Verbesselt R; Willems L
    Eur J Clin Microbiol Infect Dis; 2011 Feb; 30(2):283-7. PubMed ID: 20963460
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetics of voriconazole after oral administration of single and multiple doses in African grey parrots (Psittacus erithacus timneh).
    Flammer K; Nettifee Osborne JA; Webb DJ; Foster LE; Dillard SL; Davis JL
    Am J Vet Res; 2008 Jan; 69(1):114-21. PubMed ID: 18167096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subtherapeutic itraconazole and voriconazole levels in children with cystic fibrosis.
    Bentley S; Gupta A; Balfour-Lynn IM
    J Cyst Fibros; 2013 Jul; 12(4):418-9. PubMed ID: 23103055
    [No Abstract]   [Full Text] [Related]  

  • 33. Voriconazole and fungal keratitis: a report of two treatment failures.
    Giaconi JA; Marangon FB; Miller D; Alfonso EC
    J Ocul Pharmacol Ther; 2006 Dec; 22(6):437-9. PubMed ID: 17238810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of voriconazole during continuous venovenous hemofiltration.
    Spriet I; Wauters J; Willems L
    Ther Drug Monit; 2011 Jun; 33(3):372; author reply 372. PubMed ID: 21566509
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapeutic drug monitoring of voriconazole in children.
    Chen J; Chan C; Colantonio D; Seto W
    Ther Drug Monit; 2012 Feb; 34(1):77-84. PubMed ID: 22210097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosing voriconazole in an obese patient.
    Dickmeyer NJ; Kiel PJ
    Clin Infect Dis; 2011 Oct; 53(7):745. PubMed ID: 21846833
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration.
    Fuhrmann V; Schenk P; Jaeger W; Miksits M; Kneidinger N; Warszawska J; Holzinger U; Kitzberger R; Thalhammer F
    J Antimicrob Chemother; 2007 Nov; 60(5):1085-90. PubMed ID: 17855725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Voriconazole in clinical practice.
    Mikulska M; Novelli A; Aversa F; Cesaro S; de Rosa FG; Girmenia C; Micozzi A; Sanguinetti M; Viscoli C
    J Chemother; 2012 Dec; 24(6):311-27. PubMed ID: 23174096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience.
    Racil Z; Winterova J; Kouba M; Zak P; Malaskova L; Buresova L; Toskova M; Lengerova M; Kocmanova I; Weinbergerova B; Timilsina S; Rolencova M; Cetkovsky P; Mayer J
    Mycoses; 2012 Nov; 55(6):483-92. PubMed ID: 22429709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study.
    Soler-Palacín P; Frick MA; Martín-Nalda A; Lanaspa M; Pou L; Roselló E; de Heredia CD; Figueras C
    J Antimicrob Chemother; 2012 Mar; 67(3):700-6. PubMed ID: 22190607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.